Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety of Linaclotide in CC or IBS-C
NCT00730171Phase 3Completed
- Sponsor
- Ironwood Pharmaceuticals
- Start
- Sep 2008
- Primary completion
- Mar 2012
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of linaclotide in chronic constipation, irritable bowel syndrome (IBS), sponsored by Ironwood Pharmaceuticals. Started Sep 2008; status: completed.
02
Drugs
linaclotide
03
Conditions
chronic constipationirritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT00730171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730171.